Novel Imaging Approaches to Cardiac Manifestations of Systemic Inflammatory Diseases: JACC Scientific Statement
- PMID: 37993205
- PMCID: PMC11238243
- DOI: 10.1016/j.jacc.2023.09.819
Novel Imaging Approaches to Cardiac Manifestations of Systemic Inflammatory Diseases: JACC Scientific Statement
Abstract
Derangements in the innate and adaptive immune responses observed in systemic inflammatory syndromes contributes to unique elevated atherosclerotic risk and incident cardiovascular disease. Novel multimodality imaging techniques may improve diagnostic precision for the screening and monitoring of disease activity. The integrated application of these technologies lead to earlier diagnosis and noninvasive monitoring of cardiac involvement in systemic inflammatory diseases that will aid in preclinical studies, enhance patient selection, and provide surrogate endpoints in clinical trials, thereby improving clinical outcomes. We review the common cardiovascular manifestations of immune-mediated systemic inflammatory diseases and address the clinical and investigational role of advanced multimodality cardiac imaging.
Keywords: PET; cardiac magnetic resonance; computed tomography; echocardiography; systemic inflammatory disease.
Copyright © 2023 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Funding Support and Author Disclosures Dr Weber has received funding support from the National Institutes of Health National Heart, Lung, and Blood Institute K23HL159276-02 and American Heart Association 21CDA851511; and has served on the Scientific Advisory Board of Novo Nordisk, Horizon Therapeutics, and Kiniksa. Dr Paik has received funding support from the National Institutes of Health NIAMS K23AR073927-03. Dr Klein has received research grants from and served on the scientific advisory board of Kiniksa and Cardiology Therapeutics. Dr Yu has received funding support from the National Institutes of Health National Heart, Lung, and Blood Institute R01HL159443-02 and National Institutes of Health NIAMS R01AR057374-09. Dr Mukherjee has received funding support from the National Institutes of Health National Heart, Lung, and Blood Institute R01HL162851 and National Scleroderma Foundation; and has served on the Data Safety Monitoring Board of Advarra, Inc. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
